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ABSTRACT: Label-free high-throughput screening using mass
spectrometry has the potential to provide rapid large-scale sample
analysis at a speed of more than one sample per second. Such
speed is important for compound library, assay and future clinical
screening of millions of samples within a reasonable time frame.
Herein, we present a liquid atmospheric pressure matrix-assisted
laser desorption/ionization (AP-MALDI) setup for high-through-
put large-scale sample analysis (>5 samples per second) for three
substance classes (peptides, antibiotics, and lipids). Liquid support
matrices (LSM) were used for the analysis of standard substances
as well as complex biological ﬂuids (milk). Throughput and
analytical robustness were mainly dependent on the complexity of
the sample composition and the current limitations of the commercial hardware. However, the ultimate limits of liquid AP-MALDI
in sample throughput can be conservatively estimated to be beyond 10−20 samples per second. This level of analytical speed is
highly competitive compared with other label-free MS methods, including electrospray ionization and solid state MALDI, as well as
MS methods using multiplexing by labeling, which in principle can also be used in combination with liquid AP-MALDI MS.
Label-free high-throughput screening (HTS) of largesample sets using mass spectrometry (MS) has gained
increased attention in recent years.1−5 Especially, the reduced
numbers of false positive or negative results is a particular
advantage in contrast to the non-MS label-based screening
approaches such as ﬂuorescence-based assays.6,7 The latter also
require elaborate sample preparations using costly labels such
as dyes.
So far the main focus for mass spectrometric HTS has been
on electrospray ionization (ESI)8 and solid-state matrix-
assisted laser desorption/ionization (MALDI)9 as ionization
techniques, and a critical review has been published recently.10
ESI is a versatile and well-studied platform for the ionization
of a broad range of pharmaceutically interesting com-
pounds.11−16 However, a major drawback of ESI is a lack of
speed in the supply of samples, which is a prerequisite for HTS
applications. The fastest commercially available system using
ESI is the Agilent RapidFire for which a maximum throughput
of 2.5 s per sample was reported without using the supplied
solid-phase extraction.17
Solid-state MALDI achieved an analytical speed of up to 2.5
samples per second (0.4 s per sample) for certain analytes
using the Bruker RapiﬂeX Pharma Pulse.9 However, the time
for spotting and the actual biochemical assay were considerably
longer. Acoustic Mist Ionization (AMI) and Desorption
Electrospray Ionization (DESI) yielded comparable through-
put with 0.45 s18 and 0.4 s19 per sample, respectively.
For the diﬀerent MS ionization methods, biochemical
matrices or necessary assay components can be challenging
due to their imparted ion signal suppression,18 impeding
crystallization in the case of MALDI or being generally
incompatible with the necessary requirements regarding the
sample environment or mass spectrometry (nonvolatile salts).
However, the suitability of commonly used buﬀers for MS
analysis was investigated20 and it was shown that label-based
non-MS assays can be readily adapted for MALDI MS
analysis.2 The implementation of an additional MALDI spot
washing step oﬀers the possibility to reduce buﬀer concen-
trations and hence make more assays accessible for analysis
with MALDI MS.9
Liquid atmospheric pressure (AP) MALDI combines the
advantages of both the analysis speed of conventional solid-
state MALDI under AP and the versatility of ESI. Diﬀerent
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types of biomolecules21−23 can be analyzed over a wide range
of pH values24 and in a complex biological matrix,25 illustrating
the general suitability of liquid AP-MALDI for biochemical
screening assays. Additionally, the predominant formation of
multiply charged analyte ions oﬀers the possibility for further
target characterization by highly informative MS/MS.26
■ EXPERIMENTAL SECTION
AP-MALDI MS. A detailed description of the in-house
developed AP-MALDI setup can be found in a previous
publication.27 Brieﬂy, a heated transfer tube (1 mm internal
diameter, 6 cm length) was placed at the inlet of a Synapt G2-
Si HDMS instrument (Waters, Wilmslow, U.K.). Ions were
generated using a pulsed 337 nm nitrogen laser (3 ns pulse
duration; 30 Hz pulse repetition rate) and extracted from a
target plate across a gap of approximately 3 mm to the ion
transfer tube with a potential diﬀerence of 3.5 kV. A counter
N2 gas ﬂow of 180 L/h was applied to the ion transfer tube.
Target plate movement was achieved using a Waters Research
Enabled Software (WREnS)-controlled xy-stage and its start
was synchronized with the start of the MS data acquisition.
Data acquisition was set to TOF, sensitivity and positive ion
mode with an m/z range of 100−2000. Manual calibration was
performed by AP-LDI using sodium iodide and an acquisition
time of 3 min with an m/z range of 100−2000 using Intellistart
(MassLynx; Waters).
Materials. Ethylene glycol, propylene glycol, glycerol,
water, tris base (trizma), acetonitrile (MeCN), triﬂuoroactic
acid (TFA), bradykinin, α-cyano-4-hydroxycinnamic acid
(CHCA), 2,5-dihydroxybenzoic acid (DHB), ampicillin
sodium salt (AMP), and penicillinase from Bacillus cereus
were purchased from Sigma-Aldrich (Gillingham, U.K.).
Solid MALDI Sample Preparation. Solid MALDI
samples were prepared by mixing matrix solution with analyte
solution at a ratio of 1:1 (v/v), spotting 1 μL of the mixture
onto the target plate and leaving it to dry at room temperature.
The CHCA matrix solution was prepared by dissolving CHCA
in 0.1% TFA/MeCN (50:50; v/v) to yield a ﬁnal
concentration of 10 mg/mL. Similarly, a 20 mg/mL DHB
matrix solution was prepared in 0.1% TFA/MeCN (70:30; v/
v).
Liquid MALDI Sample Preparation. Liquid MALDI
samples were prepared by mixing a liquid support matrix
(LSM) with analyte solution at a ratio of 1:1 (v/v). The LSM
consisted of a CHCA solution (5−30 mg/mL, 50:50 or 70:30
H2O/MeCN; v/v) with ethylene or propylene glycol added
equal to 60−70% of the solution volume. For milk lipid
extracts glycerol-based LSM was used to enhance droplet
stability.
For the lactamase assay, an aqueous solution of AMP was
prepared at a concentration of 50 μg/mL. The penicillinase
was dissolved in 0.1 M tris buﬀer around pH 8 to a ﬁnal
concentration of 1800−3600 units/mL. Tris buﬀer or enzyme
solution were respectively added to AMP and incubated in a
block heater for 2 h at 35 °C.
Milk for lipid analysis was obtained from the dairy cow herd
at the Centre for Dairy Research (CEDAR) at the University
of Reading (UoR). A total of 100 milk samples were collected
from 100 healthy cows through a Dairymaster 50 rotary parlor
(Dairymaster Ltd., Bromsgrove, U.K.). All milk samples were
pooled and stored in 2 mL cryotubes at −80 °C.
Prior to the analysis, one cryotube of milk was defrosted at
room temperature for 5 min and 50 μL of pooled milk was
aliquoted in 1.5 mL tubes. The aliquots (50 μL) were mixed
with 450 μL of hexane/isopropanol (3:2; v/v) and vortexed for
5 s. No centrifugation was required, and the supernatant (lipids
fraction) was directly used as analyte solution for analysis.
■ RESULTS AND DISCUSSION
Subsecond sample analyses require data acquisition with
signiﬁcantly faster scan rates in order to obtain an adequate
number of sampling points. This is critical for accurate
recording of each sample’s ion signal as well as the separation
of individual subsequent samples in high-throughput applica-
tions. Thus, using the liquid AP-MALDI source, analyses were
carried out in TOF mode without ion mobility measurement.
The MS scan time was set between 0.1 and 0.03 s and the
interscan delay time to its shortest value (0.01 s), which
resulted in an actual interscan delay time of 50 ms due to data
transfer restrictions and automated software-driven delay time
adjustment.
Bradykinin was selected as a peptidic analyte standard for
the proof of principle of high-throughput analysis using liquid
AP-MALDI MS. A commercial 96-well MALDI sample plate
(Waters) was manually spotted with a mixture of the LSM and
analyte. Figure 1 shows the results that can be obtained by
moving the plate at a speed of approximately 5 mm/s. At this
speed 96 samples spotted in 8 rows were analyzed in
approximately 76 s, that is, 1.3 samples per second. As the
plate moved at a constant speed across each row, the MALDI
samples were irradiated by the laser only for a fraction of the
time. In addition, as the laser pulse repetition rate was not
synchronized with the sample presentation rate, the laser
randomly irradiated diﬀerent areas of the sample droplets,
arguably leading to some ﬂuctuation in sample-to-sample ion
signal intensities due to the dome shape of the sample droplets
and the laser beam’s angle of incidence on the MALDI sample
Figure 1. (a) Liquid AP-MALDI extracted ion chromatogram (m/z
530.79) of 96 sample wells with bradykinin as analyte (1 μL total
sample volume spotted, 25 pmol analyte on target) at 5 mm/s stage
movement speed. (b) Mass spectrum of all scans acquired for the ﬁrst
sample. (c) Mass spectrum of all scans acquired for the last sample.
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plate of approximately 60°. Additionally, the eﬀect of
deceleration and acceleration of the stage at the turning points
caused some peak broadening at these positions. Yet, all
sample spots yielded intense analyte ion signals with low
sample-to-sample variation and subsequent samples were easily
distinguished. It should be noted here that liquid MALDI can
produce “ESI-like” multiply charged ions and therefore the
base peak in the MALDI sample spectra is in all cases the
doubly protonated bradykinin ion signal (see Figure 1b,c).
As the next step, a slightly faster stage for the MALDI plate
was installed and a simple biochemical assay to detect
lactamase activity was chosen to demonstrate the potential of
liquid AP-MALDI MS for screening assays. The β-lactam
antibiotic ampicillin was incubated for 2 h with penicillinase in
the appropriate buﬀer as well as with buﬀer only (control). A
target plate was then spotted with MALDI samples consisting
of LSM with water as analyte solution (blank), LSM with
ampicillin in buﬀer only (control), and LSM with lactamase-
treated ampicillin in buﬀer. Because of the geometrical
constraints of the setup with the new stage (due to the larger
footprint of the new stage and space restrictions of the current
setup), only 11 of the 12 columns could be used and a total of
88 MALDI samples were spotted and irradiated. Figure 2
displays the total ion chromatogram (TIC) and selected
extracted ion chromatograms (XICs) obtained from analyzing
all 88 samples with a stage movement speed of 26 mm/s.
The XIC for CHCA (m/z 190.05; Figure 2b) shows 11
peaks at higher intensity for the spots where matrix was only
spotted with water (blank). The sodiated ampicillin ion signal
at m/z 372.1 was only detected when the MALDI samples with
ampicillin but without lactamase were irradiated (Figure 2c).
Strong ion signals at m/z 346 were only detected from the
Figure 2. Liquid AP-MALDI MS ion chromatograms of 88 samples consisting of LSM with water only (“blank”), LSM with ampicillin incubated
with penicillinase (64.1 amol on target; “enzyme”) and without penicillinase (“control”) acquired at 0.18 s/sample (26 mm/s) speed. Some of the
“enzyme” and “control” samples were alternatingly spotted in the two middle rows of the sample plate (“alternate”). (a) Total ion chromatogram
and extracted ion chromatogram of (b) protonated CHCA, (c) sodiated intact ampicillin, and (d) sodiated decarboxylated hydrolyzed ampicillin.
(e) Mass spectra of all scans for each respective sample as indicated in the chromatograms (m/z 190.04 protonated CHCA, m/z 346.12 sodiated
decarboxylated hydrolyzed ampicillin, m/z 372.10 sodiated intact ampicillin).
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samples with the penicillinase-incubated ampicillin (Figure
2d). These ion signals can be assigned to the sodium adduct
ions of the decarboxylated hydrolyzed ampicillin, a typical
product of lactamase treatment. As seen in Figure 2,
unambiguous identiﬁcation of treated and untreated ampicillin
samples can be made. Virtually no carryover between the
samples was observed.
Importantly, the analytical speed demonstrated by the
analysis of these assay samples is >5.5 samples per second,
which is twice as fast as the latest published data for HTS
analysis of large sample sets by mass spectrometry.9,18
However, the current maximum laser pulse repetition rate
and the instrument’s scan and interscan delay times arguably
result in some limitations with respect to the ion signal
intensity and stability, explaining some of the ion signal
ﬂuctuations in Figure 2. At a laser pulse repetition rate of 30
Hz and a stage speed of 26 mm/s each sample will be
irradiated by only three laser shots, since the sample diameter
is ∼2.5 mm. Thus, as indicated earlier some samples will be
irradiated with two laser shots hitting the laser beam-facing
side of the dome-shaped sample droplet and one laser shot
hitting the shadow side of the droplet while others will have
the opposite irradiation pattern as there is no synchronization
between laser pulse repetition rate and sample presentation
rate. Thus, higher laser pulse repetition rates (1 kHz or more)
and a reduction of the instrument’s scan and interscan delay
times should allow for analytical speeds well beyond 10
samples per second with much-improved ion signal abundance
and stability.
With the above-mentioned restrictions of the faster stage
and speed, 88 samples of bradykinin were also analyzed using
this new stage. For further comparison, both liquid and solid
AP-MALDI MS data were acquired. As expected, the liquid
AP-MALDI MS data of this experiment (see Figure 3a) show a
similar ion signal stability compared to the penicillinase assay
data but a slightly worse ion signal stability compared to the
earlier bradykinin data due to the lower number of laser shots
(≤3 vs approximately 15) and scans per sample and their
associated limitations on ion signal stability as discussed above.
However, the comparison to the solid AP-MALDI MS data
(see Figure 3) clearly shows that the predominant analyte ion
signal in solid AP-MALDI MS is the singly, not doubly,
charged protonated bradykinin ion (see Figure 3c−e), and
more importantly, that the ion signal intensity and stability is
signiﬁcantly worse with many samples (scans), showing only
poor or no analyte ion signal (see Figure 3b).
Finally, this method was applied to the analysis of
heterogeneous bioﬂuid. Bovine milk was collected at the
University of Reading’s research farm at CEDAR, and after a
short, one-pot sample preparation, samples were spotted as
Figure 3. (a) Liquid AP-MALDI extracted ion chromatogram of 88 sample wells (1 μL total sample volume spotted, 25 pmol analyte on target) at
26 mm/s stage movement speed for doubly charged bradykinin. (b) Solid AP-MALDI extracted ion chromatogram of 88 sample wells (1 μL total
sample volume spotted, 25 pmol analyte on target) at 26 mm/s stage movement speed for singly charged bradykinin using DHB as matrix. (c)
Mass spectrum obtained under the above high-throughput screening conditions from all (3) scans of one liquid AP-MALDI sample. (d) Mass
spectrum obtained under the above high-throughput screening conditions from all (3) scans of one solid AP-MALDI sample prepared with DHB.
(e) Mass spectrum obtained from one solid AP-MALDI sample prepared with CHCA but manually acquired over 100 scans (>100 laser shots). For
solid AP-MALDI samples prepared with CHCA, bradykinin was not detected under the above automated high-throughput screening conditions
using similar laser energies needed for DHB to produce bradykinin ion signals.
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described before. To achieve a good signal-to-noise ratio for
analyte detection, somewhat longer acquisition times, that is,
approximately 1 s per sample, were chosen with the stage
moving fast from sample to sample while spending more time
on each sample.
For all sample spots, mass spectra with good signal-to-noise
ratios were obtained (see Figure 4), highlighting the suitability
of liquid AP-MALDI for the fast analysis of complex biological
samples. As the stage resides longer on each sample and more
importantly on a speciﬁc similar spot on each sample, the ion
signal for each spot becomes more rectangularly shaped, again
indicating that similarly well-deﬁned ion signals should be
obtained with higher laser pulse repetition rates at faster stage
movement (and faster scan times and less interscan delay). For
selected peaks MS/MS data were acquired and characteristic
fragment peaks at m/z 184.07 were found, indicating the loss
of the headgroup of glycerophospholipids. Similar peaks for
bovine milk were reported earlier.28
■ CONCLUSION
The data presented demonstrate that liquid AP-MALDI is
suitable for high-throughput sample screening with a speed of
greater than 5 samples per second for the analysis of peptides,
lipids, and antibiotics. A simple biochemical assay was
conducted and a clear distinction between converted and
nonconverted substrate for each sample was achieved. The
technique was successfully applied to complex raw milk
extracts, although a somewhat lower analysis speed was chosen
to obtain quality spectra with a multitude of lipid species. The
sample throughput obtained with liquid AP-MALDI is higher
compared to those recently reported for the RapiﬂeX and
RapidFire techniques. For the more complex milk samples,
currently lower speeds are applied, which are still highly
competitive with ESI-based systems.
Further advancement toward higher throughput can be
achieved using MALDI sample plate formats with smaller
volumes and sample spacing. Preliminary experiments with
384-well plates using 0.4 μL sample volume have shown the
importance of spotting reproducibility and the use of higher
laser pulse repetition rates. For the 96-well plate (2.5 mm
sample diameter) in this study, up to three laser pulses are used
for one sample at 30 Hz laser pulse repetition rate and 26 mm/
s sample movement speed. Thus, TIC variations may be due to
only two laser shots hitting the sample and diﬀerent laser
ﬂuences caused by the angle of the sample droplet. For lower
volume plates, these eﬀects will become even more
pronounced. Hence, higher laser pulse repetition rates
combined with less interscan delay and faster scan times
should further enhance performance of the technique,
especially regarding reproducibility.
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